BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3095105)

  • 21. Biological properties of a novel follicle-stimulating hormone/human chorionic gonadotropin chimeric gonadotropin.
    Garone LM; Ammannati E; Brush TS; Fischer DJ; Tos EG; Luo J; Altobello KL; Ciampolillo C; Ihley TM; Kurosawa E; Tiebout A; McKenna S
    Endocrinology; 2006 Sep; 147(9):4205-12. PubMed ID: 16794004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovulatory follicle dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of luteolysis.
    Giordano JO; Edwards JL; Di Croce FA; Roper D; Rohrbach NR; Saxton AM; Schuenemann GM; Prado TM; Schrick FN
    Theriogenology; 2013 May; 79(8):1210-7. PubMed ID: 23534994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of follicle-stimulating hormone by a factor in a bovine serum albumin preparation.
    Caron PJ; Blithe DL; Nisula BC
    Biol Reprod; 1986 Oct; 35(3):717-23. PubMed ID: 3098315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicle stimulating activity of human chorionic gonadotropin: effect of dissociation and recombination of subunits.
    Louvet JP; Harman SM; Nisula BC; Ross GT; Birken S; Canfield R
    Endocrinology; 1976 Oct; 99(4):1126-8. PubMed ID: 976192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of hCG and its characterization by radioimmunoassay, enzyme-immunoassay, and radio-receptor assay.
    Prasad PV; Chaube SK; Shrivastav TG; Kumari GL; Duraiswami S; Muralidhar K
    J Immunoassay Immunochem; 2005; 26(4):325-44. PubMed ID: 16153017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatomedin-C enhances induction of luteinizing hormone receptors by follicle-stimulating hormone in cultured rat granulosa cells.
    Adashi EY; Resnick CE; Svoboda ME; Van Wyk JJ
    Endocrinology; 1985 Jun; 116(6):2369-75. PubMed ID: 2986948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preimplantation embryo development and serum steroid levels in immature rats induced to ovulate or superovulate with pregnant mares' serum gonadotropin injection or follicle-stimulating hormone infusions.
    Leveille MC; Armstrong DT
    Gamete Res; 1989 May; 23(1):127-38. PubMed ID: 2501205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in granulosa cells of developing rat follicles.
    Rao IM; Mills TM; Anderson E; Mahesh VB
    Anat Rec; 1991 Feb; 229(2):177-85. PubMed ID: 2012304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy.
    Kato Y; Braunstein GD
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1197-201. PubMed ID: 2453528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of proteins in pooled human follicular fluid which suppress follicular response to gonadotropins.
    diZerega GS; Marrs RP; Roche PC; Campeau JD; Kling OR
    J Clin Endocrinol Metab; 1983 Jan; 56(1):35-41. PubMed ID: 6401185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory actions of a gonadotropin-releasing hormone agonist on ovarian follicle-stimulating hormone receptors and adenylate cyclase in vivo.
    Ranta T; Baukal A; Knecht M; Korhonen M; Catt KJ
    Endocrinology; 1983 Mar; 112(3):956-64. PubMed ID: 6295748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of human chorionic gonadotropin and prolactin on 20 alpha-hydroxysteroid dehydrogenase activity in granulosa cells of immature rat ovary.
    Eckstein B; Nimrod A
    Endocrinology; 1979 Mar; 104(3):711-4. PubMed ID: 436730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a small molecular size urinary immunoreactive human chorionic gonadotropin (hCG)-like substance produced by normal placenta and by hCG-secreting neoplasms.
    Masure HR; Jaffee WL; Sickel MA; Birken S; Canfield RE; Vaitukaitis JL
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1014-20. PubMed ID: 6270179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a physiological role of gonadotropin-releasing hormone (GnRH) or GnRH-like material in the ovary.
    Birnbaumer L; Shahabi N; Rivier J; Vale W
    Endocrinology; 1985 Apr; 116(4):1367-70. PubMed ID: 3918852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta.
    Blithe DL; Akar AH; Wehmann RE; Nisula BC
    Endocrinology; 1988 Jan; 122(1):173-80. PubMed ID: 2446856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal control of epidermal growth factor receptors by gonadotropins during granulosa cell differentiation.
    Feng P; Knecht M; Catt K
    Endocrinology; 1987 Mar; 120(3):1121-6. PubMed ID: 3100284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue distribution and hormonal regulation of messenger ribonucleic acid for regulatory and catalytic subunits of adenosine 3',5'-monophosphate-dependent protein kinases during ovarian follicular development and luteinization in the rat.
    Hedin L; McKnight GS; Lifka J; Durica JM; Richards JS
    Endocrinology; 1987 May; 120(5):1928-35. PubMed ID: 3032573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women.
    Filicori M; Cognigni GE; Tabarelli C; Pocognoli P; Taraborrelli S; Spettoli D; Ciampaglia W
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1156-61. PubMed ID: 11889180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
    Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
    Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.